MicroRNA-153-3p enhances cell radiosensitivity by targeting BCL2 in human glioma

BACKGROUND: Glioma is the most prevalent malignant tumor in human central nervous systems. Recently, the development of resistance to radiotherapy in glioma patients markedly vitiates the therapy outcome. MiR-153-3p has been reported to be closely correlated with tumor progression, but its effect an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Deyu, Mu, Yi, Piao, Haozhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288870/
https://www.ncbi.nlm.nih.gov/pubmed/30537994
http://dx.doi.org/10.1186/s40659-018-0203-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288870/
https://www.ncbi.nlm.nih.gov/pubmed/30537994
http://dx.doi.org/10.1186/s40659-018-0203-6

Ejemplares similares